You are here: Industry Insights > HPV

News List

Rec-Biotechnology Went to Hong Kong, S.A.R., China IPO, Aiming at the HPV Vaccine Market Worth Tens of Billions and Creating an Innovation Engine of Comprehensive Vaccine PharmaSources/Yefenghong
August 02, 2021
On July 16, Rec-Biotechnology submitted its prospectus to HKEX and was accepted. Rec-Biotechnology is an innovative vaccine company, and its core product, Human Papillomavirus 9-valent Vaccine, Recombinant, is in Phase III clinical trial stage.
HPV Vaccination Could Rid U.S. of Most Mouth, Throat Cancers in Men drugs
December 23, 2021
How do you prevent nearly 1 million cases of mouth and throat cancers in American men in this century?
New NCCN Guidelines help Patients Better Understand and Participate in the Care of their Cervical Cancer prnasia
December 14, 2021
The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Cervical Cancer to help people with cervical cancer become more informed...
HPV Vaccine Is Reducing Cervical Cancers in Teens, Young Women Drugs
December 01, 2021
The first wave of girls to receive the HPV vaccine are much less likely to contract or die from cervical cancer than women just a few years older, a new study reports.
Could a Single Dose of the HPV Vaccine Be Enough? Drugs
November 29, 2021
Women getting vaccinated against the cancer-causing human papillomavirus (HPV) now need two or three shots, but an African clinical trial suggests a single dose is just as effective.
HPV shots expected to benefit world NMPA
November 01, 2021
The World Health Organization's recent approval of China's first self-developed vaccine against the human papillomavirus is expected to expand affordable access to the cancer-preventing doses...
Worldwide Human Papillomavirus Testing Industry to 2026 - Introduction of HPV Primary Screening Tests Presents Opportunities prnewswire
October 13, 2021
The "Human Papillomavirus Testing Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer prnasia
June 22, 2021
The National Comprehensive Cancer Network (NCCN®) announced the publication of new NCCN Guidelines for Patients® Anal Cancer, in addition to recently updated patient guidelines for colon and rectal cancers.
ASCO: Incidence of Cervical Cancer Has Decreased in the United States drugs
June 02, 2021
The incidence of cervical cancer has decreased, while the incidence of other human papillomavirus (HPV), according to a study scheduled to be presented at the annual meeting of the American Society of of Clinical Oncology, held virtually from June 4 to 8.
BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology prnasia
April 15, 2021
BioVaxys Technology Corp., the world leader in haptenized antigen vaccines for antiviral and cancers applications, is pleased to announce the results of a clinical study conducted by ProCare Health Iberia, its EU partner for marketing its ...

Previous page 1 2 3 4 5 6 Next page